Raras
Buscar doenças, sintomas, genes...
Fusariose
ORPHA:228119CID-10 · B48.7CID-11 · 1F2ZDOENÇA RARA

A fusariose é uma infecção causada por um tipo de fungo, o Fusarium, que pode ser superficial, invadir uma área próxima ou se espalhar por todo o corpo. Esse fungo é encontrado na terra e na água, e a infecção geralmente acontece quando ele entra no corpo através de um ferimento. Ela pode causar inflamação da córnea (nos olhos), micose nas unhas e, com menos frequência, inflamação do peritônio (uma membrana na barriga) ou celulite infecciosa (uma infecção da pele). Em pessoas com o sistema imunológico enfraquecido, a fusariose espalhada pelo corpo é mais comum e se manifesta com febre que não cede, lesões na pele (feridas que podem ulcerar, lesões em formato de alvo e vários caroços sob a pele), dores musculares intensas e infecções nos seios da face e nos pulmões.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A fusariose é uma infecção causada por um tipo de fungo, o Fusarium, que pode ser superficial, invadir uma área próxima ou se espalhar por todo o corpo. Esse fungo é encontrado na terra e na água, e a infecção geralmente acontece quando ele entra no corpo através de um ferimento. Ela pode causar inflamação da córnea (nos olhos), micose nas unhas e, com menos frequência, inflamação do peritônio (uma membrana na barriga) ou celulite infecciosa (uma infecção da pele). Em pessoas com o sistema imunológico enfraquecido, a fusariose espalhada pelo corpo é mais comum e se manifesta com febre que não cede, lesões na pele (feridas que podem ulcerar, lesões em formato de alvo e vários caroços sob a pele), dores musculares intensas e infecções nos seios da face e nos pulmões.

Pesquisas ativas
1 ensaio
6 total registrados no ClinicalTrials.gov
Publicações científicas
657 artigos
Último publicado: 2026 Mar 31

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: B48.7
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫁
Pulmão
8 sintomas
🩸
Sangue
5 sintomas
🧬
Pele e cabelo
5 sintomas
🛡️
Imunológico
3 sintomas
📏
Crescimento
2 sintomas
🫃
Digestivo
1 sintomas

+ 19 sintomas em outras categorias

Características mais comuns

90%prev.
Teste de 1,3 beta glucana no sangue positivo
Muito frequente (99-80%)
55%prev.
Pneumonia
Frequente (79-30%)
55%prev.
Imunodeficiência
Frequente (79-30%)
55%prev.
Febre
Frequente (79-30%)
55%prev.
Anormalidade regional da pele
Frequente (79-30%)
55%prev.
Infecção fúngica invasiva
Frequente (79-30%)
48sintomas
Muito frequente (1)
Frequente (8)
Ocasional (18)
Muito raro (21)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 48 características clínicas mais associadas, ordenadas por frequência.

Teste de 1,3 beta glucana no sangue positivoPositive blood 1,3 beta glucan test
Muito frequente (99-80%)90%
Pneumonia
Frequente (79-30%)55%
ImunodeficiênciaImmunodeficiency
Frequente (79-30%)55%
FebreFever
Frequente (79-30%)55%
Anormalidade regional da peleRegional abnormality of skin
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico657PubMed
Últimos 10 anos200publicações
Pico202576 papers
Linha do tempo
2026Hoje · 2026🧪 2007Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Fusariose

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

6 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
368 papers (10 anos)
#1

Evaluating Photochemical Interactions Between Rose Bengal Photodynamic Antimicrobial Therapy and Topical Antifungals in Fungal Keratitis Isolates.

Investigative ophthalmology &amp; visual science2026 Jan 05

The purpose of this study was to evaluate the in vitro effects of combining rose bengal (RB) photodynamic antimicrobial therapy (PDAT) with conventional topical antifungals (amphotericin B, natamycin, and voriconazole) on clinical Fusarium and Aspergillus isolates and to determine the antifungal stability under experimental conditions. Clinical isolates of Fusarium spp. (n = 3) and Aspergillus spp. (n = 3) were cultured using standard microbiology techniques. Agar plates were prepared with three concentrations of amphotericin B, natamycin, or voriconazole along with plates containing no antifungals. The following groups were tested in both dark and light conditions: (1) antifungal monotherapy (antifungal only), (2) RB monotherapy (RB only), and (3) antifungal and RB combination therapy. Plates were incubated for 7 days and percent growth inhibition was quantified. UV-visible spectroscopy and mass spectrometry was performed to assess antifungal stability. Overall, Fusarium isolates were more susceptible to RB-PDAT than Aspergillus isolates. RB-PDAT combination therapy with natamycin reduced growth inhibition, whereas combination therapy with voriconazole increased growth inhibition compared to antifungal monotherapy. UV-visible spectroscopy demonstrated 70% degradation of amphotericin B and full degradation of natamycin when combined with RB-PDAT, whereas voriconazole remained stable. Across both Fusarium and Aspergillus isolates, treatment responses to antifungals with or without RB-PDAT demonstrated strain-specific effects. The increased fungal inhibition and maintained stability of voriconazole when combined with RB-PDAT highlight its potential compatibility with RB-PDAT. In contrast, the reduced inhibition and degradation of natamycin and amphotericin B with RB-PDAT suggests that drug stability may be a factor to consider when integrating RB-PDAT into fungal keratitis management.

#2

Disseminated Fungal Infection in Profoundly Immunocompromised Hosts: A Three-Case Series.

Cureus2026 Feb

Disseminated fungal infection (DFI) is uncommon in the general population but represents a severe and frequently fatal complication in immunocompromised patients, particularly those with hematologic malignancies and prolonged neutropenia. In high-risk settings, invasive fungal infections occur with clinically meaningful frequency; a large systematic review of critically ill patients reported a pooled prevalence of invasive fungal infection of approximately 5%, highlighting that while DFI is uncommon in the general population, serious fungal disease is encountered more frequently in select high-risk cohorts. We report a case series of three immunocompromised patients with DFI to highlight shared clinical patterns, diagnostic limitations, and poor outcomes. Two patients developed disseminated fusariosis with pulmonary nodules and characteristic necrotic cutaneous lesions, while the third developed Scedosporium prolificans fungemia with pulmonary involvement and progressive encephalopathy concerning for early central nervous system (CNS) dissemination. Diagnosis required a multimodal approach, including tissue biopsy, bronchoalveolar lavage (BAL), blood cultures, and advanced molecular testing; however, precise quantification of diagnostic delay was not systematically available across cases. In this series, diagnosis was nonetheless delayed relative to initial clinical presentation, largely due to nonspecific radiographic findings, initially negative or indeterminate cultures, overlap with bacterial or noninfectious etiologies, and the need for invasive sampling in profoundly cytopenic patients. Management was further limited by intrinsic antifungal resistance, drug toxicity, and failure of immune recovery; despite aggressive therapy, all patients experienced rapid clinical deterioration over days to weeks following diagnosis, culminating in death or transition to hospice care. These cases underscore the aggressive nature of DFI in profoundly immunocompromised hosts, the central role of neutropenia in facilitating dissemination, and the need for early recognition, multidisciplinary management, and timely goals-of-care discussions when DFI occurs in the setting of advanced immunosuppression.

#3

Surgical Aspects of Patients With Leukemic Testicular Infiltration.

European journal of haematology2026 Mar 18

Leukemia is the most common childhood cancer, accounting for one-third of malignancies in this age group. Testicular infiltration in pediatric leukemia patients represents a manifestation of leukemic dissemination beyond the bone marrow and can occur at diagnosis or be a sign of relapse. Testicular infiltration may occur particularly in specific leukemia subtypes, such as acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) and is an important prognostic factor, as it may indicate an increased risk of leukemia relapse. Therefore, rigorous follow-up is essential to detect testicular infiltration early and initiate appropriate treatment. This study aims to evaluate cases of leukemia with testicular infiltration in two pediatric oncology referral centers in two different countries. We conducted a retrospective study of patients presenting with secondary testicular infiltration due to leukemia over a 14-year period (January 2010 to December 2023). During the study period, we identified 24 patients who developed testicular infiltration secondary to leukemia. All cases of testicular infiltration were diagnosed at the time of disease relapse. Fourteen patients presented with isolated testicular relapse, while the remaining patients had additional relapse sites in combination with testicular recurrence: bone marrow (10 cases) and central nervous system (2 cases). The mean age at diagnosis was 7.91 years. The average leukocyte count at diagnosis was 56 211/mm3, with only five patients presenting with leukocyte counts above 100 000/mm3. Four children (16.6%) were diagnosed with T-cell ALL, 20 (83.4%) with B-cell ALL. Fifteen patients (62.5%) underwent hematopoietic stem cell transplantation, including two haploidentical transplants. Twelve patients (50%) died-three due to disease progression and one from disseminated fusariosis. Data regarding the cause of death were unavailable for the remaining patients. The average follow-up duration was 5.87 years, with an event-free survival of 2.085 years. Although rare, testicular infiltration in leukemia patients is a clinically significant phenomenon that may affect both prognosis and quality of life. Early diagnosis and appropriate treatment of the underlying leukemia are crucial to improve outcomes. Monitoring of testicular function and fertility-related concerns must also be addressed comprehensively in patient management. Future studies with larger cohorts and standardized management protocols are essential to establish clear guidelines for the diagnosis, treatment, and follow-up of patients with testicular relapse secondary to ALL. Given the low number of cases and the diversity of local resources worldwide (especially regarding radiotherapy and endocrine follow up), the best approach for each patient should be determined in multidisciplinary team discussions.

#4

Novel antifungal compounds against Fusarium spp: A systematic review.

Enfermedades infecciosas y microbiologia clinica (English ed.)2026 Mar

Fusarium spp. has increased in relevance due to its resistance, high mortality, increasing incidence, and low preventability. The scarce treatment options compelled the development of antifungals with novel mechanisms of action. We conducted a systematic review to report on novel compounds and their activity on Fusarium spp. We searched for terms related to novel antifungals against Fusarium across multiple databases, up to February 2024. From 622 articles, only 15 articles met the eligibility criteria. The antifungals reported were manogepix (10), olorofim (3), ibrexafungerp (1), and MGCD290 (1), evaluated against 480 Fusarium isolates. Manogepix MIC/MECs had broad ranges for most Fusarium species, with notable exceptions like F. solani (MEC: ≤0.12μg/mL) and F. fujikuroi (MEC: ≤0.25μg/mL). Olorofim could be a good candidate for fusariosis treatment based on in vitro activity. Ibrexafungerp and MGCD290 did not show good activity as monotherapy. Further work on applications and development of new treatments against the resistant Fusarium species is essential.

#5

Fusariosis in Patients With Hematologic Malignancies in the Era of Antifungal Prophylaxis.

Transplant infectious disease : an official journal of the Transplantation Society2026 Mar 08

Invasive fusariosis (IF) is an uncommon but frequently fatal infection among patients with hematologic malignancies (HM). Despite widespread mould-active prophylaxis, breakthrough infections and treatment failures may occur. We aim to describe the clinical epidemiology, diagnostic approaches, antifungal management strategies, and outcomes of IF in the era of routine antifungal prophylaxis. We conducted a retrospective study of all cancer patients diagnosed with IF at a tertiary cancer center that met probable/proven criteria for IF from 2015 to 2024. We collected data on demographics, oncologic history, diagnostics, therapy, and outcomes. Twenty-two patients met criteria for proven IF. Most had acute myeloid leukemia (73%), and many underwent prior hematopoietic cell transplant (36%); nearly all were neutropenic (96%, median:48 days). Skin was the most common clinical site of infection (68%), followed by sino-pulmonary involvement (41%); fungemia occurred in 32%. Fever (77%) and skin nodules (64%) were frequent, while serum galactomannan was uniformly negative. Most common species complex was Fusarium fujikuroi. In our cohort, 82% occurred during antifungal prophylaxis, most often posaconazole. Minimum inhibitory concentrations were high for azoles and lower for amphotericin B and terbinafine. Antifungal regimens ranged from monotherapy to triple therapy. Overall mortality was 68%, of which 45% of deaths were attributed to IF. Mortality did not differ by antifungal regimen, species complexes, or presence of fungemia. IF remains a life-threatening infection in patients with HM, often presenting as disseminated disease, despite prophylaxis. High azole MICs and the observed diversity of antifungal regimens highlight the ongoing uncertainty regarding optimal treatment and the need for prospective studies to define the role of combination therapy.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC292 artigos no totalmostrando 199

2026

Disseminated Fungal Infection in Profoundly Immunocompromised Hosts: A Three-Case Series.

Cureus
2026

Surgical Aspects of Patients With Leukemic Testicular Infiltration.

European journal of haematology
2026

Novel antifungal compounds against Fusarium spp: A systematic review.

Enfermedades infecciosas y microbiologia clinica (English ed.)
2026

Fusariosis in Patients With Hematologic Malignancies in the Era of Antifungal Prophylaxis.

Transplant infectious disease : an official journal of the Transplantation Society
2026

Invasive Fusariosis Among Patients with Acute Leukemia: A 12-Year Single-Center Experience in a Middle-Income Country.

Mycopathologia
2026

Assessment of the molecular identification algorithm and its impact on antifungal susceptibilities against clinical Fusarium isolates: a multicentre study in Taiwan, 2011-2023.

JAC-antimicrobial resistance
2026

Regulation of ABC Transporters and Ergosterol Biosynthesis by the Transcription Factor FvADS-1 Controls Azole Resistance and Virulence in Fusarium verticillioides.

Journal of fungi (Basel, Switzerland)
2026

Invasive Fusariosis: Unusual Cases over 10 Years in a Tertiary Care Hospital and a Review of the Literature from Saudi Arabia.

Infectious disease reports
2026

Cutaneous Fusariosis in a Pediatric Patient With Leukemia: A Diagnostic and Therapeutic Challenge.

Cureus
2026

Dual-target recombinase polymerase amplification-lateral flow strip (RPA-LFS) for rapid detection of HSV-1 and Fusarium keratoplasticum in infectious keratitis.

Experimental eye research
2026

Fusarium keratoplasticum infection in diabetic foot ulcers following antimicrobial therapy.

Diagnostic microbiology and infectious disease
2026

Cross-Kingdom Global Proteomics Reveals Specific Modulation of Disease Signaling in Multi-Host Fungal Pathogen Infection in Chickpea and Worm.

Journal of proteome research
2026

Emergence of Fusarium oxysporum infection in farmed Labeo rohita: Isolation, growth requirements, antifungal response, and pathogenic potential.

Veterinary research communications
2026

Management of fusariosis in transplant patients.

Expert review of anti-infective therapy
2026

Antifungal activity of AR-12 and its derivatives against clinically relevant fusarium solani isolates in keratitis.

Bioorganic chemistry
2026

Duplex droplet digital PCR (ddPCR) improves the diagnosis of Aspergillus and Fusarium keratitis.

Experimental eye research
2025

A Case of Invasive Fusariosis in an Immunosuppressed Patient.

Infectious diseases &amp; clinical microbiology
2026

TLR9-mediated activation of the NLRP3 inflammasome in Fusarium solani-induced keratitis.

Experimental eye research
2026

Evaluating Photochemical Interactions Between Rose Bengal Photodynamic Antimicrobial Therapy and Topical Antifungals in Fungal Keratitis Isolates.

Investigative ophthalmology &amp; visual science
2026

Skin signs of invasive fungal diseases: diagnostic clues for clinicians.

Current opinion in infectious diseases
2025

PFKFB3 alleviates the advancement of Fusarium solani keratitis by attenuating macrophage inflammation.

Frontiers in cellular and infection microbiology
2025

Ex Vivo Goat Corneal Model for Investigating Host Immune Responses and Antifungal Drug Testing in Fusarium Keratitis.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
2026

Ultraviolet C (UV-C) Light Therapy Inhibits Pathogens Associated With Equine Keratomycosis at Different Corneal Depths-An Ex Vivo Study.

Veterinary ophthalmology
2025

Novel use of hyperbaric oxygen treatment for treatment-resistant disseminated Saksenaea and Fusarium in a patient on extracorporeal membrane oxygenation (ECMO): a case report.

Diving and hyperbaric medicine
2025

Successful treatment of a resistant invasive disseminated Fusarium infection in an immunocompetent patient.

Medical mycology case reports
2025

Invasive mould infection in children - advances made or obstacles remaining?

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
2026

Fusarium incarnatum: a paradigm for One Health pathogen dynamics across humans, animals, and the environment.

Microbiology spectrum
2025

Prevalence and diversity of antifungal resistance in Fusarium isolates across clinical and agricultural settings in the United States.

Antimicrobial agents and chemotherapy
2025

Prevalence of Fusarium sp. in juvenile olive ridley sea turtles (Lepidochelys olivacea) kept at the Centro de Conservación Marina, Taxisco, Santa Rosa, Guatemala.

Open veterinary journal
2025

Invasive fusariosis after CD19 chimeric antigen receptor T-cell therapy.

ASM case reports
2026

The first case of subcutaneous Fusariosis in an immunocompetent host in China: A case report.

Diagnostic microbiology and infectious disease
2025

A 3D Fusarium keratitis model reveals isolate-specific adhesion and invasion properties in the Fusarium solani species complex.

mSphere
2025

Fusarium oxysporum Endogenous Endophthalmitis After Allogeneic Hematopoietic Stem Cell Transplantation.

Ocular immunology and inflammation
2025

Clinical Features and Outcomes of Invasive Fusarium Infections from a Singaporean Centre: Is It Time to Redefine How We Assess Treatment Outcomes?

Journal of fungi (Basel, Switzerland)
2025

Endogenous Endophthalmitis: An underestimated serious complication in patients with disseminated fusariosis.

Medical mycology case reports
2025

Review of Fusariosis in Patients with Hematologic Malignancies.

Radiology. Imaging cancer
2025

Fusarium solani Activates PANoptosis and Modulates Immune Response in Fungal Keratitis.

Investigative ophthalmology &amp; visual science
2025

Unveiling the molecular arsenal: genome sequencing and in silico secretome analysis of Fusarium verticillioides provide insights into maize root rot pathogenesis.

Frontiers in plant science
2025

High azole MICs in Fusarium spp.: a key factor in treatment decisions for cancer patients?

Revista do Instituto de Medicina Tropical de Sao Paulo
2025

Resistance Screening and Targeted Metabolomics Identify Potential Biomarkers for Resistance in African Eggplant Against Fusarium elaeidis Wilt.

Physiologia plantarum
2025

Isolation and molecular identification of pathogens causing sea turtle egg fusariosis in key nesting beaches in Costa Rica.

PloS one
2025

SA-XV, a 15-amino acid fragment of host defense peptide S100A12, targets mitochondria and is protective against fungal infections.

The Journal of biological chemistry
2025

Pre-Colonization of Bacillus siamensis on Ocular Surface Mitigates Fusarium keratitis Through Direct Antifungal Activity and Pre-Activation of NF-κB Pathway.

Investigative ophthalmology &amp; visual science
2025

In vivo Fusarium virulence and efficacy of voriconazole in a Galleria mellonella model of invasive fusariosis.

Journal of microbiological methods
2025

A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile.

PloS one
2025

Transcriptomic Characterization of Candidate Genes for Fusarium Resistance in Maize (Zea mays L.).

Pathogens (Basel, Switzerland)
2025

From Morphology to Multi-Omics: A New Age of Fusarium Research.

Pathogens (Basel, Switzerland)
2025

Detection of Fusarium solani using cutinase antibody and its application in diagnosing fungal keratitis in an animal model.

PloS one
2025

Pentraxin 3 as a Potential Biomarker of Invasive Fusariosis in Onco-Haematological Patients.

Mycoses
2025

Epidemiological shifts of invasive fungal infections in the current era of haematology.

Medical mycology
2025

Unveiling purine metabolism targets in the pathogenesis of fungal Keratitis: A combined proteomics and metabolomics approach.

Experimental eye research
2025

Fungal infections in burn patients: The rise of Fusarium as the most prevalent in a burn center in Mexico City.

Medical mycology
2025

Natural flowering control of pineapple 'Pérola' and 'Vitória' using aviglycine hydrochloride.

Frontiers in plant science
2025

Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosis.

bioRxiv : the preprint server for biology
2026

Characterization and Aggressiveness of Fusarium spp. Associated with Root and Stem Rot in Carica papaya in Northeast Brazil.

Plant disease
2025

Evaluation of the potential for diagnosis of fungal keratitis using a Fusarium-specific antibody.

Scientific reports
2025

Fusarium keratitis on the rise in southern Europe: Implications of contact lens use and global warming.

Journal francais d'ophtalmologie
2025

Host-specific adaptation in Fusarium oxysporum correlates with distinct accessory chromosome content in human and plant pathogenic strains.

mBio
2025

New Therapeutic Options for Fusariosis: A Patent Review (2008-2023).

Journal of fungi (Basel, Switzerland)
2025

Targeting fungal keratitis: In vivo efficacy of corneal-targeting and non-targeting peptides againstFusarium dimerum.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
2025

OCT Characterization and Monitoring of Fusarium solani Chorioretinitis Lesions.

Ocular immunology and inflammation
2025

Disseminated Fusariosis in a Pediatric Patient With Acute Lymphoblastic Leukemia.

The Pediatric infectious disease journal
2025

Fusarium spp. and Aspergillus flavus infection induces pathogen-specific and pathogen-independent host immune response in patients with fungal keratitis.

Frontiers in cellular and infection microbiology
2025

A fatal case of fungemia due to Fusarium thapsinum in a patient with lung cancer.

Diagnostic microbiology and infectious disease
2025

In vitro activity of novel antifungals, natamycin, and terbinafine against Fusarium.

Antimicrobial agents and chemotherapy
2025

Propranolol is efficacious against Aspergillus and Fusarium corneal isolates in vitro and in a murine model of Aspergillus keratitis.

Antimicrobial agents and chemotherapy
2025

The Influence of the Non-Pathogenic Fusarium oxysporum Fo47 Strain on Flax Resistance to Pathogens.

International journal of molecular sciences
2025

'Unemat Rubi', a new spineless pineapple cultivar and resistant to fusariosis for the international market.

Scientific reports
2025

Effect of Streptomyces spp. metabolites and the combination of biochar and compost on Fusarium graminearum inhibition, triticale growth, and soil properties.

The Science of the total environment
2025

Antifungal susceptibility and clinical efficacy of chlorhexidine combined with topical ophthalmic medications against Fusarium species isolated from corneal samples.

Frontiers in cellular and infection microbiology
2025

The Dual Pathogen Fusarium: Diseases, Incidence, Azole Resistance, and Biofilms.

Journal of fungi (Basel, Switzerland)
2025

Clinical and Hospital Environmental Fusarium in Taiwan: Molecular Identification, Antifungal Susceptibilities, and Phylogenetic Analyses.

Mycoses
2025

Disseminated Fusariosis Successfully Treated with Empirical Liposomal Amphotericin B and Voriconazole Combination Followed by Ocular Therapy in an Allogenic Hematopoietic Stem Cell Transplant Recipient.

Internal medicine (Tokyo, Japan)
2025

Spermidine treatment limits the development of the fungus in flax shoots by suppressing polyamine metabolism and balanced defence reactions, thus increasing flax resistance to fusariosis.

Frontiers in plant science
2025

Metagenomic Identification of Fusarium solani Strain as Cause of US Fungal Meningitis Outbreak Associated with Surgical Procedures in Mexico, 2023.

Emerging infectious diseases
2025

Novel amplified fragment length polymorphism (AFLP) markers for typing medically relevant Fusarium and allied fusarioid genera.

Fungal systematics and evolution
2025

Efficacy assessments of SF001, a next-generation polyene antifungal, in a neutropenic mouse model of invasive fusariosis.

Antimicrobial agents and chemotherapy
2025

Sustainable disease management in tomatoes: Fe3O4 nanoparticles as an eco-friendly alternative to conventional fungicides for Fusarium wilt control.

Pest management science
2025

Long Non-Coding RNA Osr2 Promotes Fusarium solani Keratitis Inflammation via the miR-30a-3p/ Xcr1 Axis.

Investigative ophthalmology &amp; visual science
2025

Favourable outcome of Fusarium prosthetic valve endocarditis in a patient with an Ebstein anomaly.

Southern African journal of infectious diseases
2025

COVID-19-associated invasive fungal infections in intensive care unit patients during the first pandemic waves in Argentina: Results of a single center experience.

Medical mycology
2025

Non-Candida mycosis in Gulf Cooperation Council (GCC) countries: perspective of a low-incidence region.

BMC infectious diseases
2025

Fusarium Fungemia of T-lymphoblastic Lymphoma after HSCT: a Case Report and Review of the Literature.

Clinical laboratory
2025

Molecular Tracking of Emerging Fusarium Species in Keratitis: F. veterinarium, F. contaminatum, and F. curvatum.

Mycopathologia
2025

Dirt Under the Finger-Nails-More Malignant Than Malignancy.

American journal of hematology
2025

[Investigation of the Antifungal Susceptibility and Virulence Factors of Fusarium Strains Isolated from Clinical Samples].

Mikrobiyoloji bulteni
2025

Trachemys scripta Eggs as Part of a Potential In Vivo Model for Studying Sea Turtle Egg Fusariosis.

Journal of fungi (Basel, Switzerland)
2025

Antifungal susceptibility, clinical findings, and biofilm resistance of Fusarium species causing keratitis: a challenge for disease control.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
2025

Molecular Identification and Antifungal Susceptibility of Fusarium spp. Clinical Isolates.

Mycoses
2025

Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012-2022).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2025

8-Hydroxyquinoline derivative as a promising antifungal agent to combat ocular fungal infections.

Journal of medical microbiology
2024

Genomic Insights into Fusarium verticillioides Diversity: The Genome of Two Clinical Isolates and Their Demethylase Inhibitor Fungicides Susceptibility.

Pathogens (Basel, Switzerland)
2024

Nails and skin co-infection by Fusarium verticillioides and Proteus vulgaris secondary to arterial occlusion of lower extremity.

Revista iberoamericana de micologia
2024

Navigating the Fusarium species complex: Host-range plasticity and genome variations.

Fungal biology
2025

An Update on Fungal Disease Outbreaks of Public Health Concern.

Infectious disease clinics of North America
2024

Biofilm Formation in Clinical Isolates of Fusarium.

Journal of fungi (Basel, Switzerland)
2025

[Translated article] Angioinvasive Fusariosis with Cutaneous Manifestations After Hematopoietic Stem Cell Transplantation.

Actas dermo-sifiliograficas
2024

Fusarium spp. causing invasive disease in humans: A case series from north India.

Medical mycology
2024

Disseminated Fusarium keratoplasticum Infection with Myocardial Involvement in an Adult Cord Blood Transplant Recipient.

Mycopathologia
2025

Onychomycosis in the US Pediatric Population-An Emphasis on Fusarium Onychomycosis.

Pediatric dermatology
2024

Clinical characteristics and outcomes of Fusarium infections in adult patients after hematopoietic stem cell transplantation: A meta-summary of case reports.

Hematology/oncology and stem cell therapy
2024

Septic arthritis as breakthrough invasive fusariosis after cord blood transplantation.

Leukemia research reports
2024

Fusariosis in the Sphere.

Open forum infectious diseases
2024

A simple culture medium for phenotypic characterization and long-term storage of medically relevant fusarioid fungi.

Journal of microbiological methods
2025

Idiopathic Fusarium Sclerouveitis: A Case Report.

Cornea
2024

Identification and antifungal sensitivity of Fusarium species isolated from piscine hosts.

Diseases of aquatic organisms
2024

A gap-free genome assembly of Fusarium oxysporum f. sp. conglutinans, a vascular wilt pathogen.

Scientific data
2025

Disseminated fusariosis after allogenic hematopoietic stem cell transplantation: case report.

Infection
2024

Fusarium Keratitis: A Systematic Review (1969 to 2023).

Mycopathologia
2024

Endogenous Fusarium Endophthalmitis after Bone Marrow Transplant: A Case Report and Literature Review.

Vision (Basel, Switzerland)
2024

Pseudonectria keratitis-emerging pathogenic fungi in the eye.

Annals of clinical microbiology and antimicrobials
2024

Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis.

Transplant infectious disease : an official journal of the Transplantation Society
2024

Cutaneous fusarium disease and leukaemias: A systematic review.

Mycoses
2024

Breaking Down the Barriers of Drug Resistance and Corneal Permeability with Chitosan-Poly(ethylene glycol)-LK13 Peptide Conjugate to Combat Fungal Keratitis.

ACS infectious diseases
2024

Cold atmospheric plasma inactivates Aspergillus flavus and Fusarium keratoplasticum biofilms and conidia in vitro.

Journal of medical microbiology
2024

Mycotoxicoses in Veterinary Medicine: Fusarium Toxins, Grass Staggers, and Neothyphodium Toxins.

Frontiers in bioscience (Elite edition)
2024

Fusarium species,Scedosporium species, and Lomentospora prolificans: A systematic review to inform the World Health Organization priority list of fungal pathogens.

Medical mycology
2024

Successful Treatment of Disseminated Fusariosis in a 15-Month-old Boy With Refractory Acute Lymphoblastic Leukemia Using High-dose Voriconazole.

The Pediatric infectious disease journal
2024

Penetrative Ionic Organic Molecular Cage Nanozyme for the Targeted Treatment of Keratomycosis.

Advanced healthcare materials
2024

Fusarioid keratitis and other superficial infections: A 10-years prospective study from Northeastern Brazil.

PLoS neglected tropical diseases
2024

Landscape of Invasive Fusariosis in Pediatric Cancer Patients: Results of a Multicenter Observational Study From Latin America.

Open forum infectious diseases
2025

Precision Medicine Approach Using Triple Combination Antifungal Therapy for Fusarium Brain Abscesses and Endocarditis in an Adult Burn Patient.

Military medicine
2025

Virulence of Fusarium oxysporum strains causing corneal or plant disease is associated with their distinct accessory chromosomes.

bioRxiv : the preprint server for biology
2024

Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2024

Fusarium keratitis in a Brazilian tropical semi-arid area: Clinical-epidemiological features, molecular identification and antifungal susceptibility.

Mycoses
2024

Clinical spectrum of fusariosis from a tertiary care center in India- a retrospective study.

Iranian journal of microbiology
2024

Antifungal and Antivirulence Activity of Vanillin and Tannic Acid Against Aspergillus fumigatus and Fusarium solani.

Current microbiology
2024

Hyalohyphomycosis (Fusariosis): Atypical Presentation in an Immunocompetent Individual Responding to Itraconazole.

Indian dermatology online journal
2024

FoPGDB: a pangenome database of Fusarium oxysporum, a cross-kingdom fungal pathogen.

Database : the journal of biological databases and curation
2024

Fusarium species central nervous system infection.

Current opinion in infectious diseases
2024

PCR diagnostic platforms for non-Aspergillus mold infections: ready for routine implementation in the clinic?

Expert review of molecular diagnostics
2025

Invasive Fusariosis With Nasal Septum Involvement: Case Report of a 7-Year-Old Boy.

Actas dermo-sifiliograficas
2024

Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordance Between Responses of Skin Lesions and Systemic Outcomes.

Open forum infectious diseases
2024

Fusariosis in burn patients: A systematic review of case reports.

Medical mycology
2024

Outbreak of Fusarium solani Meningitis in Immunocompetent Persons Associated With Neuraxial Blockade in Durango, Mexico, 2022-2023.

Open forum infectious diseases
2024

Onion Fusarium Basal Rot Disease Control by Arbuscular Mycorrhizal Fungi and Trichoderma harzianum.

Plants (Basel, Switzerland)
2024

Oligogalacturonide application increases resistance to Fusarium head blight in durum wheat.

Journal of experimental botany
2024

Neurovascular Complications of Iatrogenic Fusarium solani Meningitis.

The New England journal of medicine
2024

Invasive fungal rhinosinusitis by Fusarium proliferatum/annulatum in a patient with acute myeloid leukemia: A case report and review of the literature.

Journal de mycologie medicale
2024

Multicenter Retrospective Study of Invasive Fusariosis in Intensive Care Units, France.

Emerging infectious diseases
2024

Genome-Wide Identification of DUF668 Gene Family and Expression Analysis under F. solani, Chilling, and Waterlogging Stresses in Zingiber officinale.

International journal of molecular sciences
2024

Eczematoid Cutaneous Fusariosis in a 7-Year-Old Boy.

Mycopathologia
2024

Genome-Wide Identification and Expression Analysis of Chitinase Genes in Watermelon under Abiotic Stimuli and Fusarium oxysporum Infection.

International journal of molecular sciences
2024

Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2024

Good Outcomes in Salvage Therapy of Fusariosis in Patients With Leukemia: Is It the Host or the Drug?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2024

Application of films developed with tilapia gelatin (Oreochromis niloticus), added with pitomba plant extract (Talisia esculenta) in Hawaii papaya.

Colloids and surfaces. B, Biointerfaces
2024

Phenotypic and molecular identification of Fusarium spp. clinical and environmental isolates.

Gaceta medica de Mexico
2024

[Gram staining of blood cultures from an oncologic patient].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
2024

Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes.

The Journal of antimicrobial chemotherapy
2023

Identification and Analysis of Candidate Genes Associated with Maize Fusarium Cob Resistance Using Next-Generation Sequencing Technology.

International journal of molecular sciences
2024

A novel case of cutaneous, nasal and systemic fusariosis in a goat.

Australian veterinary journal
2024

Extensive primary cutaneous fusariosis in a patient with burns: A case report and review of the literature.

Journal de mycologie medicale
2024

Detection of 2-ethyl-1-hexanol and its modulating effect in biofilm of Fusarium oxysporum.

Molecular microbiology
2023

Practical issues related to non-Aspergillus invasive mold infections.

Molecular aspects of medicine
2023

Isolation and characterization of Fusarium spp. From unhatched eggs of Caretta caretta in Tuscany (Italy).

Fungal biology
2023

Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience.

Transplant infectious disease : an official journal of the Transplantation Society
2023

Universal Digital High Resolution Melt for the detection of pulmonary mold infections.

bioRxiv : the preprint server for biology
2023

Identification and Expressional Analysis of siRNAs Responsive to Fusarium graminearum Infection in Wheat.

International journal of molecular sciences
2023

Fusariosis in Mexico: A 10-year retrospective series.

Medical mycology
2024

Fusarium oxysporum disseminated infection in a teenage patient with a relapse of acute lymphoblastic leukemia - Case report and review of the literature.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2023

Cutaneous Mucormycosis and Fusariosis in a Chinese Woman with CARD9 Deficiency.

Mycopathologia
2023

Invasive Fusarium rhinosinusitis in COVID-19 patients: report of three cases with successful management.

Frontiers in cellular and infection microbiology
2023

Fusariosis in patients with hematological malignancies: Two case reports.

Medical mycology case reports
2023

Secondary pulmonary infection by Fusarium solani and Aspergillus niger during systemic steroid treatment for COVID-19: A case report.

World journal of clinical cases
2023

Fusariosis in cancer patients: 13 case series report and literature review.

Biomedica : revista del Instituto Nacional de Salud
2023

Bisifusarium dimerum species complex central line-associated bloodstream infection in an immunocompetent patient.

Medical mycology case reports
2024

Fusarium Keratitis on the Rise - a Clinical Review.

Klinische Monatsblatter fur Augenheilkunde
2023

Treatment of Fusarium Infection of the Central Nervous System: A Review of Past Cases to Guide Therapy for the Ongoing 2023 Outbreak in the United States and Mexico.

Mycopathologia
2023

Utility of in-house and commercial PCR assay in diagnosis of Covid-19 associated mucormycoss in an emergency setting in a tertiary care center.

Journal of medical microbiology
2023

Acidification suppresses the natural capacity of soil microbiome to fight pathogenic Fusarium infections.

Nature communications
2024

Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment.

Mycoses
2023

Antifungal Efficacy of Luliconazole in an Experimental Rabbit Model of Fungal Keratitis Caused by Fusarium solani.

Mycopathologia
2023

A Comparative Analysis on the Innate Immune Responses of Cirrhinus mrigala Challenged with Pseudomonas aeruginosa and Fusarium oxysporum.

International journal of molecular sciences
2023

MALDI-TOF MS: A Quick Method to Detect the Susceptibility of Fusarium spp. Clinical Isolates to Amphotericin B.

Microorganisms
2023

Cell wall-related genes and lignin accumulation contribute to the root resistance in different maize (Zea mays L.) genotypes to Fusarium verticillioides (Sacc.) Nirenberg infection.

Frontiers in plant science
2023

Proteomics profiling and in silico analysis of peptides identified during Fusarium oxysporum infection in castor (Ricinus communis).

Phytochemistry
2023

Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.

Medical mycology
2023

Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease.

Open forum infectious diseases
2023

An unusual presentation of invasive Fusarium aortitis in a patient who is immunocompromised: A case report.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2023

Fusarium Keratitis From a Comprehensive Eye Health Care Facility in South India: Molecular Characterization by MALDI-TOF Versus Polymerase Chain Reaction Sequencing, Species Complex Distribution, and Clinical Correlation.

Cornea
2023

Fosmanogepix Therapy of Disseminated Fusarium Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2023

Invasive fusariosis in acute leukaemia patients-An outbreak in the haematology ward.

Mycoses
2023

Genome-Wide Identification, Expression, and Response to Fusarium Infection of the SWEET Gene Family in Garlic (Allium sativum L.).

International journal of molecular sciences
2023

Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now.

Expert review of anti-infective therapy
2023

Gapless genome assembly of Fusarium verticillioides, a filamentous fungus threatening plant and human health.

Scientific data
2023

Fusarium solani species complex infection treated with posaconazole in a liver transplantation patient; a case report.

Journal de mycologie medicale
2023

Severe cutaneous fusariosis in a patient with refractory acute myeloid leukemia.

IDCases
2023

Boosting of Voriconazole Levels With Omeprazole, A CYP450 2C19 Inhibitor.

The Pediatric infectious disease journal
2023

Endophthalmitis as the initial manifestation of invasive fusariosis in an allogeneic stem cell transplant patient: A case report.

Medical mycology case reports
2023

Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study.

Journal of fungi (Basel, Switzerland)
2023

Environmental and pathological factors affecting the hatching success of the two northernmost loggerhead sea turtle (Caretta caretta) nests.

Scientific reports
2023

Fungal aerosols in rabbit breeding environment: Metagenetic insight into PM2.5 based on third-generation sequencing technology.

Environmental research
2022

Species Diversity in the Fusarium solani (Neocosmospora) Complex and Their Pathogenicity for Plants and Humans.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections
2023

Superficial fungal infections in the south of France-is fusariosis the next emergent onychopathy?

Medical mycology
2023

Corrigendum to 'Nivolumab induces long-term remission in a patient with fusariosis' [Eur J Cancer 173 (2022) 91-94].

European journal of cancer (Oxford, England : 1990)
2022

Splenic rupture and fungal endocarditis in a pediatric patient with invasive fusariosis after allogeneic hematopoietic stem cell transplantation for aplastic anemia: A case report.

Frontiers in pediatrics
2023

Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome.

Journal of clinical immunology
2022

Successful treatment of disseminated amphotericin-resistant fusariosis in a paediatric patient with acute lymphoblastic leukaemia: a case report and literature review.

European journal of dermatology : EJD
2023

In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs.

Mycoses
Ver todos os 292 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Fusariose.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Fusariose

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Evaluating Photochemical Interactions Between Rose Bengal Photodynamic Antimicrobial Therapy and Topical Antifungals in Fungal Keratitis Isolates.
    Investigative ophthalmology &amp; visual science· 2026· PMID 41533911mais citado
  2. Disseminated Fungal Infection in Profoundly Immunocompromised Hosts: A Three-Case Series.
    Cureus· 2026· PMID 41878180mais citado
  3. Surgical Aspects of Patients With Leukemic Testicular Infiltration.
    European journal of haematology· 2026· PMID 41846574mais citado
  4. Novel antifungal compounds against Fusarium spp: A systematic review.
    Enfermedades infecciosas y microbiologia clinica (English ed.)· 2026· PMID 41802903mais citado
  5. Fusariosis in Patients With Hematologic Malignancies in the Era of Antifungal Prophylaxis.
    Transplant infectious disease : an official journal of the Transplantation Society· 2026· PMID 41797392mais citado
  6. Breakthrough invasive fusariosis under posaconazole prophylaxis in a neutropenic lymphoma patient.
    J Microbiol Immunol Infect· 2026· PMID 41935872recente
  7. Scedosporium apiospermum: An Emerging yet Overlooked Fungal Pathogen in Veterinary Medicine-A Case-Based Review.
    J Fungi (Basel)· 2026· PMID 41893126recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:228119(Orphanet)
  2. MONDO:0016426(MONDO)
  3. GARD:20570(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q18928476(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Fusariose
Compêndio · Raras BR

Fusariose

ORPHA:228119 · MONDO:0016426
Prevalência
Unknown
Herança
Not applicable
CID-10
B48.7 · Micoses oportunistas
CID-11
Ensaios
1 ativos
Início
All ages
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0276758
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades